MedPath

sumatriptan succinate

Sumatriptan Succinate Injection

Approved
Approval ID

05adc16c-4c2b-46f0-b810-bb18d4106dc5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 4, 2009

Manufacturers
FDA

JHP Pharmaceuticals LLC

DUNS: 804894611

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sumatriptan succinate

PRODUCT DETAILS

NDC Product Code42023-121
Application NumberANDA077871
Marketing CategoryC73584
Route of AdministrationSUBCUTANEOUS
Effective DateSeptember 4, 2009
Generic Namesumatriptan succinate

INGREDIENTS (3)

sumatriptan succinateActive
Quantity: 6 mg in 0.5 mL
Code: J8BDZ68989
Classification: ACTIM
sodium chlorideInactive
Quantity: 3.5 mg in 0.5 mL
Code: 451W47IQ8X
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

sumatriptan succinate - FDA Drug Approval Details